PortfoliosLab logo
MNMD vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MNMD and NVDA is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

MNMD vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mind Medicine (MindMed) Inc. (MNMD) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

0.00%500.00%1,000.00%1,500.00%2,000.00%December2025FebruaryMarchAprilMay
-25.82%
1,556.08%
MNMD
NVDA

Key characteristics

Sharpe Ratio

MNMD:

-0.42

NVDA:

0.51

Sortino Ratio

MNMD:

-0.10

NVDA:

1.02

Omega Ratio

MNMD:

0.99

NVDA:

1.13

Calmar Ratio

MNMD:

-0.32

NVDA:

0.74

Martin Ratio

MNMD:

-1.02

NVDA:

1.85

Ulcer Index

MNMD:

29.32%

NVDA:

14.81%

Daily Std Dev

MNMD:

78.35%

NVDA:

59.43%

Max Drawdown

MNMD:

-96.96%

NVDA:

-89.73%

Current Drawdown

MNMD:

-90.82%

NVDA:

-21.45%

Fundamentals

Market Cap

MNMD:

$523.57M

NVDA:

$2.79T

EPS

MNMD:

-$1.54

NVDA:

$2.94

PS Ratio

MNMD:

0.00

NVDA:

21.28

PB Ratio

MNMD:

2.17

NVDA:

35.22

Total Revenue (TTM)

MNMD:

$0.00

NVDA:

$104.45B

EBITDA (TTM)

MNMD:

-$52.43M

NVDA:

$68.38B

Returns By Period

In the year-to-date period, MNMD achieves a -7.18% return, which is significantly higher than NVDA's -12.59% return.


MNMD

YTD

-7.18%

1M

32.11%

6M

-14.10%

1Y

-32.78%

5Y*

0.51%

10Y*

N/A

NVDA

YTD

-12.59%

1M

21.88%

6M

-21.15%

1Y

29.85%

5Y*

72.35%

10Y*

72.94%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MNMD vs. NVDA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MNMD
The Risk-Adjusted Performance Rank of MNMD is 3131
Overall Rank
The Sharpe Ratio Rank of MNMD is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of MNMD is 3535
Sortino Ratio Rank
The Omega Ratio Rank of MNMD is 3535
Omega Ratio Rank
The Calmar Ratio Rank of MNMD is 3232
Calmar Ratio Rank
The Martin Ratio Rank of MNMD is 2727
Martin Ratio Rank

NVDA
The Risk-Adjusted Performance Rank of NVDA is 7171
Overall Rank
The Sharpe Ratio Rank of NVDA is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of NVDA is 6666
Sortino Ratio Rank
The Omega Ratio Rank of NVDA is 6565
Omega Ratio Rank
The Calmar Ratio Rank of NVDA is 7979
Calmar Ratio Rank
The Martin Ratio Rank of NVDA is 7272
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MNMD vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mind Medicine (MindMed) Inc. (MNMD) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MNMD Sharpe Ratio is -0.42, which is lower than the NVDA Sharpe Ratio of 0.51. The chart below compares the historical Sharpe Ratios of MNMD and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00December2025FebruaryMarchAprilMay
-0.42
0.51
MNMD
NVDA

Dividends

MNMD vs. NVDA - Dividend Comparison

MNMD has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.03%.


TTM20242023202220212020201920182017201620152014
MNMD
Mind Medicine (MindMed) Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.03%0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%

Drawdowns

MNMD vs. NVDA - Drawdown Comparison

The maximum MNMD drawdown since its inception was -96.96%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for MNMD and NVDA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-90.82%
-21.45%
MNMD
NVDA

Volatility

MNMD vs. NVDA - Volatility Comparison

Mind Medicine (MindMed) Inc. (MNMD) has a higher volatility of 23.88% compared to NVIDIA Corporation (NVDA) at 22.46%. This indicates that MNMD's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%December2025FebruaryMarchAprilMay
23.88%
22.46%
MNMD
NVDA

Financials

MNMD vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Mind Medicine (MindMed) Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00BAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250
39.33B
(MNMD) Total Revenue
(NVDA) Total Revenue
Values in USD except per share items